메뉴 건너뛰기




Volumn 33, Issue 2, 1999, Pages 131-140

Acute myocardial infarction

(2)  Dana, Ali a   Walker, Malcolm a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; ENCAINIDE; FIBRINOLYTIC AGENT; FLECAINIDE; GLYCERYL TRINITRATE; GLYCOPROTEIN; HEPARIN; INTEGRIN; ISOSORBIDE MONONITRATE; LANOTEPLASE; LIDOCAINE; MORACIZINE; NITRATE; RAMIPRIL; RETEPLASE; SARUPLASE; STAPHYLOKINASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANDOLAPRIL;

EID: 0032930826     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (5)

References (65)
  • 1
    • 0032561972 scopus 로고    scopus 로고
    • Treatment of myocardial infarction
    • Gershlik AH, More RS. Treatment of myocardial infarction. Br Med J 1998; 316:280-4.
    • (1998) Br Med J , vol.316 , pp. 280-284
    • Gershlik, A.H.1    More, R.S.2
  • 2
    • 0031577151 scopus 로고    scopus 로고
    • Clinical epidemiology of coronary heart disease in the UK
    • Gandhi MM. Clinical epidemiology of coronary heart disease in the UK. Br J Hosp Med 1997;58:23-7.
    • (1997) Br J Hosp Med , vol.58 , pp. 23-27
    • Gandhi, M.M.1
  • 3
    • 0018932163 scopus 로고
    • Prevalence of total coronary artery occlusion during the early hours of transmural myocardial infarction
    • DeWood MA, Spores J, Notske R, Mouser LT, et al. Prevalence of total coronary artery occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
    • (1980) N Engl J Med , vol.303 , pp. 897-902
    • DeWood, M.A.1    Spores, J.2    Notske, R.3    Mouser, L.T.4
  • 4
    • 0001288621 scopus 로고
    • The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy
    • Fletcher AP, Alkjaersig N, Smyrniotis FE, Sherry S. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians 1958;71:287-96.
    • (1958) Trans Assoc Am Physicians , vol.71 , pp. 287-296
    • Fletcher, A.P.1    Alkjaersig, N.2    Smyrniotis, F.E.3    Sherry, S.4
  • 5
    • 0022640774 scopus 로고
    • Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
    • Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i: 397-402.
    • (1986) Lancet , vol.1 , pp. 397-402
  • 6
    • 0023805341 scopus 로고
    • Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
    • ISIS-2 (Second International Study of Infarct Survival) Collaborators Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;ii:349-60.
    • (1988) Lancet , vol.2 , pp. 349-360
  • 7
    • 0032574630 scopus 로고    scopus 로고
    • Thrombolysis for acute myocardial infarction
    • White HD, Van de Werf FJJ. Thrombolysis for acute myocardial infarction. Circulation 1998;97:1632-46.
    • (1998) Circulation , vol.97 , pp. 1632-1646
    • White, H.D.1    Van De Werf, F.J.J.2
  • 8
    • 0027240597 scopus 로고
    • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
    • The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673-82.
    • (1993) N Engl J Med , vol.329 , pp. 673-682
  • 9
    • 0028914981 scopus 로고
    • Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: Importance of early and complete infarct artery reperfusion
    • Simes RJ, Topol EJ, Holmes DRJ, White HD, et al, for the GUSTO-I Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. Circulation 1995;91:1923-8.
    • (1995) Circulation , vol.91 , pp. 1923-1928
    • Simes, R.J.1    Topol, E.J.2    Holmes, D.R.J.3    White, H.D.4
  • 10
    • 0021916187 scopus 로고
    • Thrombolysis in Myocardial Infarction (TIMI) trial: Phase 1 findings
    • TIMI Study Group. Thrombolysis in Myocardial Infarction (TIMI) trial: phase 1 findings. N Engl J Med 1985;312:932-6.
    • (1985) N Engl J Med , vol.312 , pp. 932-936
  • 11
    • 0027424433 scopus 로고
    • The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
    • The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
    • (1993) N Engl J Med , vol.329 , pp. 1615-1622
  • 12
    • 0028039957 scopus 로고
    • Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
    • Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
    • (1994) Lancet , vol.343 , pp. 311-322
  • 13
    • 0030596903 scopus 로고    scopus 로고
    • Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
    • Boersma E, Maas ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
    • (1996) Lancet , vol.348 , pp. 771-775
    • Boersma, E.1    Maas, A.C.P.2    Deckers, J.W.3    Simoons, M.L.4
  • 14
    • 0026764571 scopus 로고
    • Time delays in provision of thrombolytic treatment in six district hospitals
    • Birkhead JS, on behalf of the Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of the Royal College of Physicians of London. Time delays in provision of thrombolytic treatment in six district hospitals. Br Med J 1992;305:445-8.
    • (1992) Br Med J , vol.305 , pp. 445-448
    • Birkhead, J.S.1
  • 15
    • 0020033705 scopus 로고
    • Early reporting of myocardial infarction; impact of an experiment on patient education
    • Rowley JM, Hill JD, Hampton JR, Mitchel JRA. Early reporting of myocardial infarction; impact of an experiment on patient education. Br Med J 1982;284:1741-6.
    • (1982) Br Med J , vol.284 , pp. 1741-1746
    • Rowley, J.M.1    Hill, J.D.2    Hampton, J.R.3    Mitchel, J.R.A.4
  • 17
    • 0026698925 scopus 로고
    • Feasibility, safety and efficacy of domiciliary thrombolysis by general practitioners; Grampian region early anistreplase trial
    • Great Group. Feasibility, safety and efficacy of domiciliary thrombolysis by general practitioners; Grampian region early anistreplase trial. Br Med J 1992; 305:548-53.
    • (1992) Br Med J , vol.305 , pp. 548-553
  • 18
    • 0003047223 scopus 로고
    • Meta-analysis of randomised trials of prehospital versus hospital thrombolysis
    • abstract
    • Fath-Ordoubadi F, Al-Mohammad A, Huehns TY, Beatt KJ. Meta-analysis of randomised trials of prehospital versus hospital thrombolysis. Circulation 1994; 90:1-325 (abstract).
    • (1994) Circulation , vol.90 , pp. 1-325
    • Fath-Ordoubadi, F.1    Al-Mohammad, A.2    Huehns, T.Y.3    Beatt, K.J.4
  • 19
    • 0029899396 scopus 로고    scopus 로고
    • Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction
    • French JK, Williams BF, Hart HH, Wyatt S, et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. Br Med J 1996;312:1637-41.
    • (1996) Br Med J , vol.312 , pp. 1637-1641
    • French, J.K.1    Williams, B.F.2    Hart, H.H.3    Wyatt, S.4
  • 20
    • 20244376615 scopus 로고
    • Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction
    • The MITI Project Group
    • Weaver WD, Litwin PE, Martin JS, Kudenchuk PJ, et al. The MITI Project Group. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol 1991;18:657-62.
    • (1991) J Am Coll Cardiol , vol.18 , pp. 657-662
    • Weaver, W.D.1    Litwin, P.E.2    Martin, J.S.3    Kudenchuk, P.J.4
  • 21
    • 0028918696 scopus 로고
    • Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients
    • Lee KL, Woodlief LH, Topol EJ, Weaver WD, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
    • (1995) Circulation , vol.91 , pp. 1659-1668
    • Lee, K.L.1    Woodlief, L.H.2    Topol, E.J.3    Weaver, W.D.4
  • 22
    • 10244242679 scopus 로고    scopus 로고
    • Age and outcome with contemporary thrombolytic therapy: Results from the GUSTO-I trial
    • White HD, Barbash GI, Califf RM, Simes RJ, et al, for the GUSTO-I Investigators. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trial. Circulation 1996;94: 1826-33.
    • (1996) Circulation , vol.94 , pp. 1826-1833
    • White, H.D.1    Barbash, G.I.2    Califf, R.M.3    Simes, R.J.4
  • 23
    • 0031541276 scopus 로고    scopus 로고
    • Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: Review of ocular haemorrhage incidence and location in the GUSTO-I trial
    • Mahaffey KW, Granger CB, Toth CA, White HD, et al, for the GUSTO-I Investigators. Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular haemorrhage incidence and location in the GUSTO-I trial. ; J Am Coll Cardiol 1997;30:1606-10.
    • (1997) J Am Coll Cardiol , vol.30 , pp. 1606-1610
    • Mahaffey, K.W.1    Granger, C.B.2    Toth, C.A.3    White, H.D.4
  • 24
    • 0027494770 scopus 로고
    • Patients with suspected myocardial infarction who present with ST depression
    • Lee HS, Cross SJ, Rawles J, Jennings K. Patients with suspected myocardial infarction who present with ST depression. Lancet 1993;342:1204-7.
    • (1993) Lancet , vol.342 , pp. 1204-1207
    • Lee, H.S.1    Cross, S.J.2    Rawles, J.3    Jennings, K.4
  • 25
    • 0030918917 scopus 로고    scopus 로고
    • Should patients with suspected acute myocardial infarction without ST elevation be given thrombolytic treatment?
    • Rawles J. Should patients with suspected acute myocardial infarction without ST elevation be given thrombolytic treatment? Eur Heart J 1997;18:899-906.
    • (1997) Eur Heart J , vol.18 , pp. 899-906
    • Rawles, J.1
  • 26
    • 0029923513 scopus 로고    scopus 로고
    • Late Assessment of Thrombolytic Efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction
    • Langer A, Goodman SG, Topol EJ, Charlesworth A, et al. Late Assessment of Thrombolytic Efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. J Am Coll Cardiol 1996;27:1327-32.
    • (1996) J Am Coll Cardiol , vol.27 , pp. 1327-1332
    • Langer, A.1    Goodman, S.G.2    Topol, E.J.3    Charlesworth, A.4
  • 27
    • 0031914990 scopus 로고    scopus 로고
    • Toward a new frontier in myocardial reperfusion therapy: Emerging platelet prominence
    • Topol EJ. Toward a new frontier in myocardial reperfusion therapy: emerging platelet prominence. Circulation 1998;97:211-8.
    • (1998) Circulation , vol.97 , pp. 211-218
    • Topol, E.J.1
  • 28
  • 29
    • 2642654221 scopus 로고    scopus 로고
    • A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
    • The PRISM Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498-505.
    • (1998) N Engl J Med , vol.338 , pp. 1498-1505
  • 30
    • 2642599026 scopus 로고    scopus 로고
    • Inhibition of the platelet glycoprotein iib/iiia receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
    • The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338: 1488-97.
    • (1998) N Engl J Med , vol.338 , pp. 1488-1497
  • 31
    • 0032560628 scopus 로고    scopus 로고
    • The PARAGON Investigators, international, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina
    • The PARAGON Investigators, international, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Circulation 1998;97:2386-95.
    • (1998) Circulation , vol.97 , pp. 2386-2395
  • 32
    • 0008926519 scopus 로고    scopus 로고
    • Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
    • The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-43.
    • (1998) N Engl J Med , vol.339 , pp. 436-443
  • 33
    • 0343849937 scopus 로고    scopus 로고
    • Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction
    • Bode C, Smalling RW, Berg G, Burnett C, et al. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. Circulation 1996;94:891-8.
    • (1996) Circulation , vol.94 , pp. 891-898
    • Bode, C.1    Smalling, R.W.2    Berg, G.3    Burnett, C.4
  • 34
    • 0029142436 scopus 로고
    • Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): Trial to investigate equivalence
    • International Joint Efficacy Comparison of Thrombolytics. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. Lancet 1995;346:329-36.
    • (1995) Lancet , vol.346 , pp. 329-336
  • 35
    • 0030879325 scopus 로고    scopus 로고
    • A comparison of reteplase with alteplase for acute myocardial infarction
    • The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997;337: 1118-23.
    • (1997) N Engl J Med , vol.337 , pp. 1118-1123
  • 36
    • 0031456844 scopus 로고    scopus 로고
    • Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
    • Weaver WD, Simes RJ, Ellis SG, Grines CL, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278:2093-8.
    • (1997) JAMA , vol.278 , pp. 2093-2098
    • Weaver, W.D.1    Simes, R.J.2    Ellis, S.G.3    Grines, C.L.4
  • 37
    • 0009522584 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of abciximab with primary angioplasty for acute MI: The RAPPORT trial
    • abstract
    • Brener SJ, Barr LA, Burchenal J, Katz S, et al. A randomized, placebo-controlled trial of abciximab with primary angioplasty for acute MI: the RAPPORT trial. Circulation 1997;96(Suppl I):I-473 (abstract).
    • (1997) Circulation , vol.96 , Issue.SUPPL. I
    • Brener, S.J.1    Barr, L.A.2    Burchenal, J.3    Katz, S.4
  • 38
    • 0032581036 scopus 로고    scopus 로고
    • Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
    • Suryapranata H, van't Hof AWJ, Hoorntje JCA, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97:2502-5.
    • (1998) Circulation , vol.97 , pp. 2502-2505
    • Suryapranata, H.1    Van't Hof, A.W.J.2    Hoorntje, J.C.A.3    De Boer, M.J.4    Zijlstra, F.5
  • 39
    • 0030937976 scopus 로고    scopus 로고
    • Analysis of the relative costs and effectiveness of primary angio-plasty versus tissue-type plasminogen activator: The Primary Angioplasty in Myocardial Infarction (PAMI) Trial
    • Stone GW, Grines CL, Rothbaum D, Brown KF, et al. Analysis of the relative costs and effectiveness of primary angio-plasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) Trial. J Am Coll Cardiol 1997;29:901-7.
    • (1997) J Am Coll Cardiol , vol.29 , pp. 901-907
    • Stone, G.W.1    Grines, C.L.2    Rothbaum, D.3    Brown, K.F.4
  • 40
    • 0025335032 scopus 로고
    • GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction
    • Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
    • (1990) Lancet , vol.336 , pp. 65-71
  • 41
    • 0026607185 scopus 로고
    • ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
    • ISIS-3 (Third International Study of Infarct Survival) Collaborators Group. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70.
    • (1992) Lancet , vol.339 , pp. 753-770
  • 42
    • 0026537021 scopus 로고
    • Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: Results of a randomised double blind European Cooperative Study Group trial
    • de Bono DP, Simoons ML, Tijssen J, Arnold AE, et al. Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. Br Heart J 1992;67:122-8.
    • (1992) Br Heart J , vol.67 , pp. 122-128
    • De Bono, D.P.1    Simoons, M.L.2    Tijssen, J.3    Arnold, A.E.4
  • 43
    • 4243304248 scopus 로고    scopus 로고
    • Time dependent effect of treatment with ASA during thrombolytic therapy in acute myocardial infarction
    • abstract
    • Freimark D, Behar S, Matetsky S, Feinberg M, Hod H. Time dependent effect of treatment with ASA during thrombolytic therapy in acute myocardial infarction. J Am Coll Cardiol 1998;31:231 A (abstract).
    • (1998) J Am Coll Cardiol , vol.31
    • Freimark, D.1    Behar, S.2    Matetsky, S.3    Feinberg, M.4    Hod, H.5
  • 44
    • 0027121751 scopus 로고
    • The use of aspirin in ischemic heart disease
    • Wilard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med 1992;327:175-81.
    • (1992) N Engl J Med , vol.327 , pp. 175-181
    • Wilard, J.E.1    Lange, R.A.2    Hillis, L.D.3
  • 45
    • 0028641402 scopus 로고
    • What happened to intravenous atenolol in acute myocardial infarction?
    • Sleight P. What happened to intravenous atenolol in acute myocardial infarction? Cardiology 1994;85:13-7.
    • (1994) Cardiology , vol.85 , pp. 13-17
    • Sleight, P.1
  • 46
    • 84888827980 scopus 로고
    • Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-I
    • ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-I. Lancet 1986;ii:57-66.
    • (1986) Lancet , vol.2 , pp. 57-66
  • 47
    • 0027491257 scopus 로고
    • Effect of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: An overview of results from randomized controlled trials
    • Teo KK, Yusuf S, Furberg CD. Effect of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993;270: 1589-95.
    • (1993) JAMA , vol.270 , pp. 1589-1595
    • Teo, K.K.1    Yusuf, S.2    Furberg, C.D.3
  • 48
    • 0019459311 scopus 로고
    • Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
    • The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
    • (1981) N Engl J Med , vol.304 , pp. 801-807
  • 49
    • 0020078179 scopus 로고
    • A randomized trial of propranolol in patients with acute myocardial infarction
    • Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-14.
    • (1982) JAMA , vol.247 , pp. 1707-1714
  • 50
    • 0032552240 scopus 로고    scopus 로고
    • Effect of beta-blockade on mortality among high risk and low-risk patients after myocardial infarction
    • Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97.
    • (1998) N Engl J Med , vol.339 , pp. 489-497
    • Gottlieb, S.S.1    McCarter, R.J.2    Vogel, R.A.3
  • 51
    • 0028932732 scopus 로고
    • ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
    • ISIS-4 (Fourth International Study of lnfarct Survival) Collaborative Croup. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345:669-85.
    • (1995) Lancet , vol.345 , pp. 669-685
  • 52
    • 0028273258 scopus 로고
    • GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
    • Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-22.
    • (1994) Lancet , vol.343 , pp. 1115-1122
  • 53
    • 0026787642 scopus 로고
    • Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
    • Swedberg K, Held P, Kjekshus J, Rasmussen K, et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992; 327:669-77.
    • (1992) N Engl J Med , vol.327 , pp. 669-677
    • Swedberg, K.1    Held, P.2    Kjekshus, J.3    Rasmussen, K.4
  • 54
    • 0031692258 scopus 로고    scopus 로고
    • Anti-ischaemic effects of ACE inhibitors: Review of current clinical evidence and ongoing clinical trials
    • Yusuf S, Lonn E. Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials. Eur Heart J 1998;19(Suppl J):J36-44.
    • (1998) Eur Heart J , vol.19 , Issue.SUPPL. J
    • Yusuf, S.1    Lonn, E.2
  • 55
    • 0027423378 scopus 로고
    • Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
    • The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
    • (1993) Lancet , vol.342 , pp. 821-828
  • 56
    • 0026786643 scopus 로고
    • Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
    • Pfeffer MA, Braunwald E, Moye LA, Basta L, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327: 669-77.
    • (1992) N Engl J Med , vol.327 , pp. 669-677
    • Pfeffer, M.A.1    Braunwald, E.2    Moye, L.A.3    Basta, L.4
  • 57
    • 9044239676 scopus 로고
    • A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
    • Kober L, Torppedersen C, Carlsen JE, Bagger H, et al. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333: 1670-6.
    • (1995) N Engl J Med , vol.333 , pp. 1670-1676
    • Kober, L.1    Torppedersen, C.2    Carlsen, J.E.3    Bagger, H.4
  • 58
    • 0030995759 scopus 로고    scopus 로고
    • Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study
    • Hall AS, Murray GD, Ball SG, on behalf of the AIREX Study Investigators. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Lancet 1997; 349:1493-7.
    • (1997) Lancet , vol.349 , pp. 1493-1497
    • Hall, A.S.1    Murray, G.D.2    Ball, S.G.3
  • 59
    • 0024312703 scopus 로고
    • Strategies to manage the post-MI patient with ventricular arrhythmias
    • Weinberg B, Zipes D. Strategies to manage the post-MI patient with ventricular arrhythmias. Clin Cardiol 1989;12:86-90.
    • (1989) Clin Cardiol , vol.12 , pp. 86-90
    • Weinberg, B.1    Zipes, D.2
  • 60
    • 0001648677 scopus 로고
    • Risk stratification and survival after myocardial infarction
    • The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:301-6.
    • (1983) N Engl J Med , vol.309 , pp. 301-306
  • 61
    • 0023694806 scopus 로고
    • Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from the randomized controlled trials
    • MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized controlled trials. JAMA 1988;260:1910-6.
    • (1988) JAMA , vol.260 , pp. 1910-1916
    • MacMahon, S.1    Collins, R.2    Peto, R.3    Koster, R.W.4    Yusuf, S.5
  • 62
    • 0026011647 scopus 로고
    • Mortality and morbidity in patients receiving encainide, flecainide or placebo: The Cardiac Arrhythmia Suppression trial. N
    • Echt DS, Liebson PR, Mitchell LB, Peters RW, et al. Mortality and morbidity in patients receiving encainide, flecainide or placebo: the Cardiac Arrhythmia Suppression trial. N Engl J Med 1991; 324:781-8.
    • (1991) Engl J Med , vol.324 , pp. 781-788
    • Echt, D.S.1    Liebson, P.R.2    Mitchell, L.B.3    Peters, R.W.4
  • 63
    • 0026752875 scopus 로고
    • Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
    • The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-33.
    • (1992) N Engl J Med , vol.327 , pp. 227-233
  • 64
    • 0031038213 scopus 로고    scopus 로고
    • Randomised trial of the effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
    • Julian DG, Camm AJ, Frangin G, Janse MJ, et al, for the European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of the effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997;349:667-74.
    • (1997) Lancet , vol.349 , pp. 667-674
    • Julian, D.G.1    Camm, A.J.2    Frangin, G.3    Janse, M.J.4
  • 65
    • 0031029373 scopus 로고    scopus 로고
    • Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
    • Cairns JA, Connolly SJ, Roberts R, Gent M, for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997;349:675-82.
    • (1997) Lancet , vol.349 , pp. 675-682
    • Cairns, J.A.1    Connolly, S.J.2    Roberts, R.3    Gent, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.